Skip to main content
. 2015 Oct 3;6(33):34414–34422. doi: 10.18632/oncotarget.5437

Table 3. Univariate analysis of overall survival in patients treated with RT and temozolomide.

Variable Hazard Ratio (95% CI) p-value
RSI RR vs. RS 1.34 (0.91,1.98) 0.14
MGMT Expression High vs. Low 1.7 (1.23,2.35) 0.002
Age 50+ vs. 50 1.76 (1.2,2.59) 0.004
ECOG 24 vs. 01 1.73 (1.14,2.64) 0.01
ECOG Unknown vs. 01 1.23 (0.73,2.07) 0.43
Gender Male vs. Female 1.07 (0.76,1.51) 0.71
Race Black vs. Asian/White 1.01 (0.45,2.29) 0.98
Race Unknown vs. Asian White 1.53 (0.48,4.82) 0.47

CI = Confidence Interval

RT = Radiotherapy

RSI = Radiosensitivity index

RS = Radiosensitive

RR = Radioresistant

MGMT = O(6)-Methylguanine-DNA methyltransferase

ECOG = Eastern Cooperative Oncology Group Performance Status